Champions Oncology Inc (NASDAQ:CSBR) Can’t Be More Risky. Short Interest Increased

Champions Oncology, Inc. (NASDAQ:CSBR) Logo

The stock of Champions Oncology Inc (NASDAQ:CSBR) registered an increase of 95.63% in short interest. CSBR’s total short interest was 125,400 shares in December as published by FINRA. Its up 95.63% from 64,100 shares, reported previously. With 32,800 shares average volume, it will take short sellers 4 days to cover their CSBR’s short positions.

The stock decreased 5.44% or $0.61 during the last trading session, reaching $10.61. About 96,620 shares traded. Champions Oncology, Inc. (NASDAQ:CSBR) has risen 168.61% since December 7, 2017 and is uptrending. It has outperformed by 152.99% the S&P500.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. The company has market cap of $118.45 million. The Company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It currently has negative earnings. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services.

More notable recent Champions Oncology, Inc. (NASDAQ:CSBR) news were published by: which released: “64 Biggest Movers From Yesterday – Stockhouse” on November 01, 2018, also with their article: “Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know –” published on November 22, 2018, published: “34 Stocks Moving In Wednesday’s Mid-Day Session – Benzinga” on November 21, 2018. More interesting news about Champions Oncology, Inc. (NASDAQ:CSBR) were released by: and their article: “Wall Street Trims Gains on Soft Retail Sales – Nasdaq” published on September 14, 2018 as well as‘s news article titled: “Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference – PR Newswire” with publication date: November 07, 2018.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.